Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Gulati

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
The Prostate|June 9, 2016
A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate CancerClaire Murphy, Lawrence True, Funda Vakar-Lopez, et al.
JAMA Health Forum|August 17, 2022
Evaluation of Prostate Cancer Screening Strategies in a Low-Resource, High-risk Population in the BahamasEveline A M Heijnsdijk, Roman Gulati, Jane M Lange, et al.
Journal of the National Cancer Institute|June 22, 2019
Overdiagnosis and Lives Saved by Reflex Testing Men With Intermediate Prostate-Specific Antigen LevelsRoman Gulati, Todd M Morgan, Teresa A'mar, et al.
Journal of the National Cancer Institute. Monographs|November 10, 2023
Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factorsRoman Gulati, Yaw A Nyame, Jane M Lange, et al.
American Journal of Epidemiology|October 17, 2018
Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening TrialsMarc D Ryser, Roman Gulati, Marisa C Eisenberg, et al.
Medical Care|December 28, 2012
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer ScreeningRuth Etzioni, Roman Gulati, Matt R Cooperberg, et al.
The American Journal of Clinical Nutrition|January 22, 2010
Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik EskimosZeina Makhoul, Alan R Kristal, Roman Gulati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2015
Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate CancerJeanette K Birnbaum, Ziding Feng, Roman Gulati, et al.
Journal of the National Cancer Institute|March 12, 2009
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and contextGerrit Draisma, Ruth Etzioni, Alex Tsodikov, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2021
Economic Evaluation of Urine-Based or Magnetic Resonance Imaging Reflex Tests in Men With Intermediate Prostate-Specific Antigen Levels in the United StatesBoshen Jiao, Roman Gulati, Nathaniel Hendrix, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
The Prostate|June 9, 2016
A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate CancerClaire Murphy, Lawrence True, Funda Vakar-Lopez, et al.
JAMA Health Forum|August 17, 2022
Evaluation of Prostate Cancer Screening Strategies in a Low-Resource, High-risk Population in the BahamasEveline A M Heijnsdijk, Roman Gulati, Jane M Lange, et al.
Journal of the National Cancer Institute|June 22, 2019
Overdiagnosis and Lives Saved by Reflex Testing Men With Intermediate Prostate-Specific Antigen LevelsRoman Gulati, Todd M Morgan, Teresa A'mar, et al.
Journal of the National Cancer Institute. Monographs|November 10, 2023
Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factorsRoman Gulati, Yaw A Nyame, Jane M Lange, et al.
American Journal of Epidemiology|October 17, 2018
Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening TrialsMarc D Ryser, Roman Gulati, Marisa C Eisenberg, et al.
Medical Care|December 28, 2012
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer ScreeningRuth Etzioni, Roman Gulati, Matt R Cooperberg, et al.
The American Journal of Clinical Nutrition|January 22, 2010
Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik EskimosZeina Makhoul, Alan R Kristal, Roman Gulati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2015
Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate CancerJeanette K Birnbaum, Ziding Feng, Roman Gulati, et al.
Journal of the National Cancer Institute|March 12, 2009
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and contextGerrit Draisma, Ruth Etzioni, Alex Tsodikov, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2021
Economic Evaluation of Urine-Based or Magnetic Resonance Imaging Reflex Tests in Men With Intermediate Prostate-Specific Antigen Levels in the United StatesBoshen Jiao, Roman Gulati, Nathaniel Hendrix, et al.
Pageof 16